Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”-Reference-Cited by-同舟云学术

Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”

Published:2023-02-13 Issue:4 Volume:15 Page:1187
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Ramai Daryl¹,Deliwala Smit S.²^ORCID,Chandan Saurabh³^ORCID,Lester Janice⁴,Singh Jameel⁵^ORCID,Samanta Jayanta⁶^ORCID,di Nunzio Sara⁷^ORCID,Perversi Fabio⁷,Cappellini Francesca⁷,Shah Aashni⁷^ORCID,Ghidini Michele⁸^ORCID,Sacco Rodolfo⁹^ORCID,Facciorusso Antonio⁹^ORCID,Giacomelli Luca⁷

Affiliation:

1. Division of Gastroenterology and Hepatology, University of Utah, Salt Lake City, UT 84112, USA

2. Department of Internal Medicine, Hurley Medical Center, Michigan State University, Flint, MI 48503, USA

3. Division of Gastroenterology & Hepatology, CHI Health Creighton University Medical Center, Omaha, NE 68131, USA

4. Health Science Library, Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY 11040, USA

5. Department of Internal Medicine, Mather Hospital, Northwell Health, Port Jefferson, NY 11777, USA

6. Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, Sector 12, Chandigarh 160012, India

7. Polistudium SRL, 20135 Milan, Italy

8. Division of Medical Oncology, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy

9. Gastroenterology Unit, Department of Surgical and Medical Sciences, University of Foggia, 71122 Foggia, Italy

Abstract

We thank Dr. Lissing and colleagues for providing us with these helpful comments [...]

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

https://www.mdpi.com/2072-6694/15/4/1187/pdf

Reference15 articles.

1. Lissing, M., Vassiliou, D., Harper, P., Sardh, E., and Wahlin, S. (2023). Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947. Cancers, 15.

2. Ramai, D., Deliwala, S.S., Chandan, S., Lester, J., Singh, J., Samanta, J., di Nunzio, S., Perversi, F., Cappellini, F., and Shah, A. (2022). Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers, 14.

3. Association of porphyria cutanea tarda and primary liver cancer: Report of ten cases;Solis;J. Dermatol.,1982

4. Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors;Salata;J. Hepatol.,1985

5. Hepatocellular carcinoma in porphyria cutanea tarda: Frequency and factors related to its occurrence;Siersema;Liver,1992